Invention Grant
- Patent Title: Lactobacillus crispatus and application thereof
-
Application No.: US15034503Application Date: 2014-10-30
-
Publication No.: US09937214B2Publication Date: 2018-04-10
- Inventor: Yang Liu
- Applicant: Suzhou Osel Bio-Pharm Co., Ltd.
- Applicant Address: CN Shijiazhuang, Hebei
- Assignee: Suzhou Osel Bio-Pharm Co., Ltd.
- Current Assignee: Suzhou Osel Bio-Pharm Co., Ltd.
- Current Assignee Address: CN Shijiazhuang, Hebei
- Agency: Knobbe Martens Olson & Bear LLP
- Priority: CN201310551630 20131108; CN201310551661 20131108; CN201310731833 20131226
- International Application: PCT/CN2014/089882 WO 20141030
- International Announcement: WO2015/067141 WO 20150514
- Main IPC: A61K35/747
- IPC: A61K35/747 ; A61K8/99 ; C12R1/225 ; A61Q19/00 ; A61K35/74 ; A61K35/00

Abstract:
The present invention discloses Lactobacillus crispatus 262-1 and an inoculum comprising such strain and application thereof. The Lactobacillus crispatus 262-1 is a new strain of Lactobacillus genus and is preserved in the China General Microbiological Culture Collection Center with a preservation number of CGMCC No. 6469. The Lactobacillus crispatus 262-1 particularly is the dominant bacteria in the vagina, has good acid and H2O2 production capability, good adhesion to the vaginal epithelial cells and significant resistance to bacterial vaginosis and various vaginal infections, and is characterized by safety, non-toxicity, good stability and long term preservation. The present invention also relates to the use of the Lactobacillus crispatus 262-1 in the preparation of pharmaceuticals for preventing and/or treating gynecological diseases and its application in feminine care products such as medical instruments, disinfect products or cosmetics.
Public/Granted literature
- US20170020934A1 LACTOBACILLUS CRISPATUS AND APPLICATION THEREOF Public/Granted day:2017-01-26
Information query
IPC分类: